Professor Arnold von Eckardstein, MD, is currently Professor of Clinical Chemistry at the University of Zurich and Director of the Institute of Clinical Chemistry of the University Hospital of Zurich.
His research interests include risk factors, biomarkers and pathogenesis of vascular disease; regulation and function of lipoproteins, especially high density lipoproteins (HDL); lipid metabolism and lipidomics. He has published about 250 original and review papers in international scientific journals.
Prof. von Eckardstein serves as Chairman of the European Lipoprotein Club and Chairman of the Executive Committee of the Swiss Working Group on Lipids and Atherosclerosis. He is the past President of the German Society of Arteriosclerosis Research and of the Swiss Society of Clinical Chemistry. He has served as vice-president of International Task Force for the Prevention of Coronary Heart Disease. He is a fellow of the American Heart Association (FAHA; Council on Arteriosclerosis, Thrombosis and Vascular Biology) and a distinguished Fellow of the International Atherosclerosis Society. He serves as editorial board member of ATVB, Atherosclerosis, Journal of Lipid Research, European Heart Journal and Clinical Chemistry and Laboratory Medicine.